Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

34.75
+0.20000.58%
Post-market: 34.810.0600+0.17%19:30 EDT
Volume:5.44M
Turnover:187.00M
Market Cap:21.69B
PE:27.47
High:35.02
Open:34.39
Low:33.73
Close:34.55
52wk High:35.91
52wk Low:23.62
Shares:624.06M
Float Shares:617.00M
Volume Ratio:1.25
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.64
PE(LYR):22.61

Loading ...

Genmab announces 5.08% stake by Orbis Investment

TIPRANKS
·
May 09

Genmab A/S reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
May 09

Genmab Shares Fall After Net Income Misses Forecast

Dow Jones
·
May 08

Genmab Q1 Net Profit Falls, Revenue Rises

MT Newswires Live
·
May 08

Genmab maintains FY26 guidance

TIPRANKS
·
May 08

Genmab Q1 EPADS $0.083 Misses $0.17 Estimate, Sales $896.000M Beat $890.400M Estimate

Benzinga Earnings
·
May 07

Press Release: Genmab Announces Financial Results for the First Quarter of 2026

Dow Jones
·
May 07

Genmab A/S Stock Rises Wednesday, Underperforms Market

Dow Jones
·
May 07

Genmab A/S expected to post earnings of 18 cents a share - Earnings Preview

Reuters
·
May 05

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
May 05

Earning Preview: Genmab A/S this quarter’s revenue is expected to increase by 17.37%, and institutional views are predominantly bullish

Earnings Agent
·
May 01

Genmab A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
May 01

Genmab Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 30

Genmab price target lowered to $38 from $40 at H.C. Wainwright

TIPRANKS
·
Apr 30

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Apr 30

Genmab: Buy Rating Backed by Expanded Petosemtamab-Keytruda Phase III Trial and Blockbuster Late-Stage Pipeline

TIPRANKS
·
Apr 28

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Apr 28

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Apr 25

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Apr 23